KPT-185 decreased XPO1 in all tested MCL cells, which is concordant with the previous reports of MCL and lung cancer cells [13, 46], in which KPT-185 induced proteasomal degradation of XPO1 protein despite its normally long half-life (24 hours) [46]. This evidence concerns the gene XPO1 and lung cancer.